PAD4 overexpression in NSCLC cells induced by pCMV-2a/2b-PAD4 transfection reversed resistance to gefitinib by inhibiting the Elk1-mediated EMT, while downregulated PAD4 expression led to the opposite effect [122]. This evidence concerns the gene ELK1 and non-small cell lung carcinoma.